Eli Lilly), which binds to and activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), retatrutide is a triple threat, targeting glucagon (GCG) in addition to GLP-1 and GIP
This is the number that got my attention: in the trial data, patients on oral semaglutide had dramatically higher discontinuation rates the "comparable" weight-loss results you see advertised only held for the small fraction who followed the strict protocol perfectly to the end
The drug works primarily by mimicking the incretin hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
If tirzepatide has frozen , do not use it
This information does not take the place of talking to your healthcare provider about your medical condition or treatment
The prices are very competitive & they have discounts regularly so its super affordable